Khalil Hassan,Anmol Baranwal,Al Rabee Kassis,Jade Braun,Gabriel Bartoo,Robert Wolf,Mehrdad Hefazi,Aasiya Matin,Abhishek Mangoankar,Mithun V Shah,Mark R Litzow,William J Hogan,David Dingli,Hassan B Alkhateeb
{"title":"基于GvHD预防的高危髓系肿瘤患者低强度调节同种异体干细胞移植后复发风险:PTCy Vs. TAC/MTX","authors":"Khalil Hassan,Anmol Baranwal,Al Rabee Kassis,Jade Braun,Gabriel Bartoo,Robert Wolf,Mehrdad Hefazi,Aasiya Matin,Abhishek Mangoankar,Mithun V Shah,Mark R Litzow,William J Hogan,David Dingli,Hassan B Alkhateeb","doi":"10.1002/ajh.70059","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7724,"journal":{"name":"American Journal of Hematology","volume":"61 1","pages":""},"PeriodicalIF":9.9000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk of Relapse Post Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With High-Risk Myeloid Neoplasms Based on GvHD Prophylaxis: PTCy Vs. TAC/MTX.\",\"authors\":\"Khalil Hassan,Anmol Baranwal,Al Rabee Kassis,Jade Braun,Gabriel Bartoo,Robert Wolf,Mehrdad Hefazi,Aasiya Matin,Abhishek Mangoankar,Mithun V Shah,Mark R Litzow,William J Hogan,David Dingli,Hassan B Alkhateeb\",\"doi\":\"10.1002/ajh.70059\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":7724,\"journal\":{\"name\":\"American Journal of Hematology\",\"volume\":\"61 1\",\"pages\":\"\"},\"PeriodicalIF\":9.9000,\"publicationDate\":\"2025-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/ajh.70059\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ajh.70059","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Risk of Relapse Post Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With High-Risk Myeloid Neoplasms Based on GvHD Prophylaxis: PTCy Vs. TAC/MTX.
期刊介绍:
The American Journal of Hematology offers extensive coverage of experimental and clinical aspects of blood diseases in humans and animal models. The journal publishes original contributions in both non-malignant and malignant hematological diseases, encompassing clinical and basic studies in areas such as hemostasis, thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports highlighting innovative therapeutic approaches for the diagnosis and treatment of hematological diseases are actively encouraged.The American Journal of Hematology features regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, as well as letters and correspondence.